ÂÜÀòÂÒÂ×

Mr. Billmayer has spent over 30 years as a leader in healthcare business development. As Senior Director of Program Development for Mayo Clinic’s spin-out pharmacogenomics company, OneOme, Mr. Billmayer developed the end-to-end plan and ensured execution. Activities included providing expertise and contributions in market landscape and strategic plan development, coverage and reimbursement, business modeling and pricing, product design and workflow integration. He was the key executive and subject matter expert on the team that secured pilot engagements and/or strategic investments with UnitedHealth Group, Optum, Anthem, LabCorp, Walgreens and Penn Medicine. More recently, Mr. Billmayer has served as a senior consultant to a tech incubator with solutions in opioid risk assessment, colon cancer screening and pharmacogenomics.